| OUTCOME |
INTERVENTION |
CONTROL |
EFFECT ESTIMATE |
| Mean |
SD |
n |
Mean |
SD |
n |
Mean difference (95%CI) |
| Overall pain (VAS 0‐100) change from baseline to 6 months |
‐22.3 |
34.1 |
49 |
‐24.3 |
24.9 |
51 |
2.00 [‐9.74, 13.74] |
| Overall pain (VAS 0‐100) change from baseline to 12 months |
‐23.9 |
27.2 |
49 |
‐23 |
27.7 |
51 |
‐0.90 [‐11.66, 9.86] |
| Function (Shoulder Disability Questionnaire 0‐100) change from baseline to 6 months |
‐38.9 |
35.5 |
49 |
‐33.2 |
27.7 |
51 |
‐5.70 [‐18.22, 6.82] |
| Function (Shoulder Disability Questionnaire 0‐100) change from baseline to 12 months |
‐50 |
30.3 |
49 |
‐38.8 |
27.4 |
51 |
‐11.20 [‐22.53, 0.13] |
| Night pain (VAS 0‐100) change from baseline to 6 months |
‐38.3 |
43.5 |
49 |
‐31.7 |
29.9 |
51 |
‐6.60 [‐21.29, 8.09] |
| Night pain (VAS 0‐100) change from baseline to 12 months |
‐43.7 |
34.5 |
49 |
‐35.9 |
30.2 |
51 |
‐7.80 [‐20.53, 4.93] |
| Pain on motion (VAS 0‐100) change from baseline to 6 months |
‐31.4 |
27.9 |
49 |
‐31.9 |
26.0 |
51 |
0.50 [‐10.06, 11.06] |
| Pain on motion (VAS 0‐100) change from baseline to 12 months |
‐39.2 |
27.9 |
49 |
‐32.6 |
31.3 |
51 |
‐6.60 [‐18.20, 5.00] |
| Active abduction (degrees) change from baseline to 6 months |
55.8 |
37.3 |
49 |
46.9 |
32.0 |
51 |
8.90 [‐4.74, 22.54] |
| Active abduction (degrees) change from baseline to 12 months |
72.9 |
31.7 |
49 |
60.3 |
32.7 |
51 |
12.60 [‐0.02, 25.22] |
| Active flexion (degrees) change from baseline to 6 months |
34.2 |
23.3 |
49 |
33.6 |
16.7 |
51 |
0.60 [‐7.38, 8.58] |
| Active flexion (degrees) change from baseline to 12 months |
47 |
24.4 |
49 |
42.9 |
19.9 |
51 |
4.10 [‐4.64, 12.84] |
| Active external rotation (degrees) change from baseline to 6 months |
15.9 |
12.9 |
49 |
13.2 |
13.2 |
51 |
2.70 [‐2.40, 7.80] |
| Active external rotation (degrees) change from baseline to 12 months |
20.8 |
11.8 |
49 |
15.9 |
16.0 |
51 |
4.90 [‐0.60, 10.40] |
| Quality of life (SF‐36 PCS 0‐100) change from baseline to 6 months |
19.2 |
18.8 |
49 |
17.1 |
17.8 |
51 |
2.10 [‐5.08, 9.28] |
| Quality of life (SF‐36 PCS 0‐100) change from baseline to 12 months |
23.2 |
21.9 |
49 |
22.8 |
19.9 |
51 |
0.40 [‐7.82, 8.62] |
| Quality of life (SF‐36 MCS 0‐100) change from baseline to 6 months |
8.2 |
20.2 |
49 |
7.9 |
21.7 |
51 |
0.30 [‐7.91, 8.51] |
| Quality of life (SF‐36 MCS 0‐100) change from baseline to 12 months |
7.7 |
20.5 |
49 |
10.2 |
22.4 |
51 |
‐2.50 [‐10.92, 5.92] |
| |
Events |
Total |
Events |
Total |
Risk ratio (95%CI) |
| Global assessment of treatment success ("better or much better") at 6 months |
40 |
49 |
43 |
51 |
0.97 [0.81, 1.16] |
| Global assessment of treatment success ("better or much better") at 12 months |
43 |
49
|
40 |
51
|
1.12 [0.94, 1.34] |
